Open AccessActivity of Eribulin Mesylate in Brain Metastasis from Breast Cancer: A Stone in a Pond?
Author(s) -
Giovanna Catania,
Paola Malaguti,
Simona Gasparro,
Francesco Cognetti,
Antonello Vidiri,
Alessandra Fabi
Publication year - 2018
Publication title -
oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.987
H-Index - 98
eISSN - 1423-0232
pISSN - 0030-2414
DOI - 10.1159/000489066
Subject(s) - eribulin , medicine , metastatic breast cancer , radiation therapy , oncology , brain metastasis , breast cancer , chemotherapy , cancer , metastasis
Brain metastases develop in approximately 10-25% of patients with metastatic breast cancer (MBC) and are associated with a very poor prognosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom